nodes	percent_of_prediction	percent_of_DWPC	metapath
Levothyroxine—SLCO1B3—Docetaxel—pancreatic cancer	0.11	0.154	CbGbCtD
Levothyroxine—SLCO1B1—Irinotecan—pancreatic cancer	0.0874	0.122	CbGbCtD
Levothyroxine—ALB—Erlotinib—pancreatic cancer	0.053	0.0742	CbGbCtD
Levothyroxine—CYP2C8—Tamoxifen—pancreatic cancer	0.0482	0.0675	CbGbCtD
Levothyroxine—ALB—Irinotecan—pancreatic cancer	0.0479	0.067	CbGbCtD
Levothyroxine—ALB—Fluorouracil—pancreatic cancer	0.0459	0.0643	CbGbCtD
Levothyroxine—CYP2C8—Erlotinib—pancreatic cancer	0.0409	0.0574	CbGbCtD
Levothyroxine—CYP2C8—Fluorouracil—pancreatic cancer	0.0355	0.0497	CbGbCtD
Levothyroxine—ABCB1—Tamoxifen—pancreatic cancer	0.0326	0.0457	CbGbCtD
Levothyroxine—ABCB1—Gemcitabine—pancreatic cancer	0.0281	0.0393	CbGbCtD
Levothyroxine—ABCB1—Erlotinib—pancreatic cancer	0.0277	0.0388	CbGbCtD
Levothyroxine—ABCB1—Irinotecan—pancreatic cancer	0.025	0.0351	CbGbCtD
Levothyroxine—CYP3A4—Tamoxifen—pancreatic cancer	0.0195	0.0274	CbGbCtD
Levothyroxine—ABCB1—Docetaxel—pancreatic cancer	0.0183	0.0257	CbGbCtD
Levothyroxine—ABCB1—Sunitinib—pancreatic cancer	0.0183	0.0256	CbGbCtD
Levothyroxine—CYP3A4—Erlotinib—pancreatic cancer	0.0166	0.0233	CbGbCtD
Levothyroxine—CYP3A4—Irinotecan—pancreatic cancer	0.015	0.021	CbGbCtD
Levothyroxine—ABCB1—Doxorubicin—pancreatic cancer	0.0137	0.0192	CbGbCtD
Levothyroxine—CYP3A4—Docetaxel—pancreatic cancer	0.011	0.0154	CbGbCtD
Levothyroxine—CYP3A4—Sunitinib—pancreatic cancer	0.0109	0.0153	CbGbCtD
Levothyroxine—CYP3A4—Doxorubicin—pancreatic cancer	0.00819	0.0115	CbGbCtD
Levothyroxine—Angina pectoris—Irinotecan—pancreatic cancer	0.000857	0.0055	CcSEcCtD
Levothyroxine—Dysphagia—Fluorouracil—pancreatic cancer	0.000843	0.00541	CcSEcCtD
Levothyroxine—Angina pectoris—Fluorouracil—pancreatic cancer	0.000821	0.00527	CcSEcCtD
Levothyroxine—Weight decreased—Irinotecan—pancreatic cancer	0.000796	0.00511	CcSEcCtD
Levothyroxine—Angioedema—Tamoxifen—pancreatic cancer	0.000794	0.0051	CcSEcCtD
Levothyroxine—Flushing—Sunitinib—pancreatic cancer	0.000794	0.00509	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Docetaxel—pancreatic cancer	0.000776	0.00498	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Irinotecan—pancreatic cancer	0.000774	0.00497	CcSEcCtD
Levothyroxine—Myocardial infarction—Irinotecan—pancreatic cancer	0.000769	0.00494	CcSEcCtD
Levothyroxine—Arrhythmia—Sunitinib—pancreatic cancer	0.000764	0.0049	CcSEcCtD
Levothyroxine—Alopecia—Sunitinib—pancreatic cancer	0.000756	0.00485	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Gemcitabine—pancreatic cancer	0.000754	0.00484	CcSEcCtD
Levothyroxine—Sweating—Irinotecan—pancreatic cancer	0.000752	0.00483	CcSEcCtD
Levothyroxine—Myocardial infarction—Gemcitabine—pancreatic cancer	0.000749	0.00481	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Fluorouracil—pancreatic cancer	0.000741	0.00476	CcSEcCtD
Levothyroxine—Arthralgia—Tamoxifen—pancreatic cancer	0.00074	0.00475	CcSEcCtD
Levothyroxine—Anxiety—Tamoxifen—pancreatic cancer	0.000738	0.00473	CcSEcCtD
Levothyroxine—Myocardial infarction—Fluorouracil—pancreatic cancer	0.000737	0.00473	CcSEcCtD
Levothyroxine—Sweating—Gemcitabine—pancreatic cancer	0.000733	0.0047	CcSEcCtD
Levothyroxine—Arthralgia—Erlotinib—pancreatic cancer	0.000732	0.0047	CcSEcCtD
Levothyroxine—Anxiety—Erlotinib—pancreatic cancer	0.00073	0.00468	CcSEcCtD
Levothyroxine—Cardiac failure—Docetaxel—pancreatic cancer	0.000721	0.00463	CcSEcCtD
Levothyroxine—Shock—Erlotinib—pancreatic cancer	0.000691	0.00443	CcSEcCtD
Levothyroxine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000686	0.0044	CcSEcCtD
Levothyroxine—Angioedema—Sunitinib—pancreatic cancer	0.00068	0.00437	CcSEcCtD
Levothyroxine—Dehydration—Docetaxel—pancreatic cancer	0.000655	0.0042	CcSEcCtD
Levothyroxine—Flushing—Irinotecan—pancreatic cancer	0.000654	0.0042	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Tamoxifen—pancreatic cancer	0.000646	0.00415	CcSEcCtD
Levothyroxine—Convulsion—Sunitinib—pancreatic cancer	0.000645	0.00414	CcSEcCtD
Levothyroxine—Insomnia—Tamoxifen—pancreatic cancer	0.000642	0.00412	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Erlotinib—pancreatic cancer	0.00064	0.0041	CcSEcCtD
Levothyroxine—Insomnia—Erlotinib—pancreatic cancer	0.000635	0.00407	CcSEcCtD
Levothyroxine—Arthralgia—Sunitinib—pancreatic cancer	0.000634	0.00407	CcSEcCtD
Levothyroxine—Dyspnoea—Tamoxifen—pancreatic cancer	0.000633	0.00406	CcSEcCtD
Levothyroxine—Arrhythmia—Irinotecan—pancreatic cancer	0.000629	0.00404	CcSEcCtD
Levothyroxine—Dyspnoea—Erlotinib—pancreatic cancer	0.000626	0.00402	CcSEcCtD
Levothyroxine—Alopecia—Irinotecan—pancreatic cancer	0.000623	0.004	CcSEcCtD
Levothyroxine—Arrhythmia—Gemcitabine—pancreatic cancer	0.000613	0.00393	CcSEcCtD
Levothyroxine—Fatigue—Tamoxifen—pancreatic cancer	0.000612	0.00393	CcSEcCtD
Levothyroxine—Dysphagia—Docetaxel—pancreatic cancer	0.000609	0.00391	CcSEcCtD
Levothyroxine—Alopecia—Gemcitabine—pancreatic cancer	0.000606	0.00389	CcSEcCtD
Levothyroxine—Fatigue—Erlotinib—pancreatic cancer	0.000605	0.00388	CcSEcCtD
Levothyroxine—Arrhythmia—Fluorouracil—pancreatic cancer	0.000603	0.00387	CcSEcCtD
Levothyroxine—Shock—Sunitinib—pancreatic cancer	0.000598	0.00384	CcSEcCtD
Levothyroxine—Coma—Epirubicin—pancreatic cancer	0.000598	0.00384	CcSEcCtD
Levothyroxine—Alopecia—Fluorouracil—pancreatic cancer	0.000596	0.00383	CcSEcCtD
Levothyroxine—Angina pectoris—Docetaxel—pancreatic cancer	0.000593	0.0038	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00058	0.00372	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000574	0.00368	CcSEcCtD
Levothyroxine—Urticaria—Tamoxifen—pancreatic cancer	0.000564	0.00362	CcSEcCtD
Levothyroxine—Abdominal pain—Tamoxifen—pancreatic cancer	0.000561	0.0036	CcSEcCtD
Levothyroxine—Abdominal pain—Erlotinib—pancreatic cancer	0.000555	0.00356	CcSEcCtD
Levothyroxine—Body temperature increased—Erlotinib—pancreatic cancer	0.000555	0.00356	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Sunitinib—pancreatic cancer	0.000554	0.00355	CcSEcCtD
Levothyroxine—Coma—Doxorubicin—pancreatic cancer	0.000553	0.00355	CcSEcCtD
Levothyroxine—Weight decreased—Docetaxel—pancreatic cancer	0.000551	0.00353	CcSEcCtD
Levothyroxine—Insomnia—Sunitinib—pancreatic cancer	0.00055	0.00353	CcSEcCtD
Levothyroxine—Dyspnoea—Sunitinib—pancreatic cancer	0.000542	0.00348	CcSEcCtD
Levothyroxine—Acute coronary syndrome—Docetaxel—pancreatic cancer	0.000535	0.00343	CcSEcCtD
Levothyroxine—Myocardial infarction—Docetaxel—pancreatic cancer	0.000532	0.00341	CcSEcCtD
Levothyroxine—Fatigue—Sunitinib—pancreatic cancer	0.000524	0.00336	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Epirubicin—pancreatic cancer	0.000524	0.00336	CcSEcCtD
Levothyroxine—Asthenia—Tamoxifen—pancreatic cancer	0.000509	0.00327	CcSEcCtD
Levothyroxine—Convulsion—Fluorouracil—pancreatic cancer	0.000509	0.00327	CcSEcCtD
Levothyroxine—Arthralgia—Gemcitabine—pancreatic cancer	0.000509	0.00326	CcSEcCtD
Levothyroxine—Increased appetite—Epirubicin—pancreatic cancer	0.000505	0.00324	CcSEcCtD
Levothyroxine—Confusional state—Irinotecan—pancreatic cancer	0.000505	0.00324	CcSEcCtD
Levothyroxine—Asthenia—Erlotinib—pancreatic cancer	0.000504	0.00323	CcSEcCtD
Levothyroxine—Pruritus—Tamoxifen—pancreatic cancer	0.000502	0.00322	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000497	0.00319	CcSEcCtD
Levothyroxine—Pruritus—Erlotinib—pancreatic cancer	0.000497	0.00319	CcSEcCtD
Levothyroxine—Shock—Irinotecan—pancreatic cancer	0.000492	0.00316	CcSEcCtD
Levothyroxine—Cardiac failure—Epirubicin—pancreatic cancer	0.000487	0.00312	CcSEcCtD
Levothyroxine—Hypoglycaemia—Epirubicin—pancreatic cancer	0.000487	0.00312	CcSEcCtD
Levothyroxine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000485	0.00312	CcSEcCtD
Levothyroxine—Cardiac failure congestive—Doxorubicin—pancreatic cancer	0.000485	0.00311	CcSEcCtD
Levothyroxine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000484	0.00311	CcSEcCtD
Levothyroxine—Confusional state—Fluorouracil—pancreatic cancer	0.000483	0.0031	CcSEcCtD
Levothyroxine—Body temperature increased—Sunitinib—pancreatic cancer	0.00048	0.00308	CcSEcCtD
Levothyroxine—Abdominal pain—Sunitinib—pancreatic cancer	0.00048	0.00308	CcSEcCtD
Levothyroxine—Diarrhoea—Erlotinib—pancreatic cancer	0.00048	0.00308	CcSEcCtD
Levothyroxine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000471	0.00303	CcSEcCtD
Levothyroxine—Tachycardia—Fluorouracil—pancreatic cancer	0.000468	0.003	CcSEcCtD
Levothyroxine—Increased appetite—Doxorubicin—pancreatic cancer	0.000468	0.003	CcSEcCtD
Levothyroxine—Affect lability—Epirubicin—pancreatic cancer	0.000467	0.003	CcSEcCtD
Levothyroxine—Insomnia—Irinotecan—pancreatic cancer	0.000453	0.00291	CcSEcCtD
Levothyroxine—Flushing—Docetaxel—pancreatic cancer	0.000452	0.0029	CcSEcCtD
Levothyroxine—Cardiac arrest—Epirubicin—pancreatic cancer	0.000452	0.0029	CcSEcCtD
Levothyroxine—Vomiting—Tamoxifen—pancreatic cancer	0.000451	0.0029	CcSEcCtD
Levothyroxine—Cardiac failure—Doxorubicin—pancreatic cancer	0.00045	0.00289	CcSEcCtD
Levothyroxine—Hypoglycaemia—Doxorubicin—pancreatic cancer	0.00045	0.00289	CcSEcCtD
Levothyroxine—Mood swings—Epirubicin—pancreatic cancer	0.00045	0.00289	CcSEcCtD
Levothyroxine—Rash—Tamoxifen—pancreatic cancer	0.000447	0.00287	CcSEcCtD
Levothyroxine—Dermatitis—Tamoxifen—pancreatic cancer	0.000447	0.00287	CcSEcCtD
Levothyroxine—Vomiting—Erlotinib—pancreatic cancer	0.000446	0.00286	CcSEcCtD
Levothyroxine—Dyspnoea—Irinotecan—pancreatic cancer	0.000446	0.00286	CcSEcCtD
Levothyroxine—Headache—Tamoxifen—pancreatic cancer	0.000444	0.00285	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	0.000444	0.00285	CcSEcCtD
Levothyroxine—Rash—Erlotinib—pancreatic cancer	0.000443	0.00284	CcSEcCtD
Levothyroxine—Dermatitis—Erlotinib—pancreatic cancer	0.000442	0.00284	CcSEcCtD
Levothyroxine—Dehydration—Epirubicin—pancreatic cancer	0.000442	0.00283	CcSEcCtD
Levothyroxine—Insomnia—Gemcitabine—pancreatic cancer	0.000441	0.00283	CcSEcCtD
Levothyroxine—Headache—Erlotinib—pancreatic cancer	0.00044	0.00282	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000437	0.0028	CcSEcCtD
Levothyroxine—Asthenia—Sunitinib—pancreatic cancer	0.000436	0.0028	CcSEcCtD
Levothyroxine—Arrhythmia—Docetaxel—pancreatic cancer	0.000435	0.00279	CcSEcCtD
Levothyroxine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000435	0.00279	CcSEcCtD
Levothyroxine—Insomnia—Fluorouracil—pancreatic cancer	0.000434	0.00278	CcSEcCtD
Levothyroxine—Affect lability—Doxorubicin—pancreatic cancer	0.000432	0.00278	CcSEcCtD
Levothyroxine—Fatigue—Irinotecan—pancreatic cancer	0.000432	0.00277	CcSEcCtD
Levothyroxine—Alopecia—Docetaxel—pancreatic cancer	0.00043	0.00276	CcSEcCtD
Levothyroxine—Pruritus—Sunitinib—pancreatic cancer	0.00043	0.00276	CcSEcCtD
Levothyroxine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000427	0.00274	CcSEcCtD
Levothyroxine—Nausea—Tamoxifen—pancreatic cancer	0.000421	0.0027	CcSEcCtD
Levothyroxine—Fatigue—Gemcitabine—pancreatic cancer	0.00042	0.0027	CcSEcCtD
Levothyroxine—Muscular weakness—Epirubicin—pancreatic cancer	0.000419	0.00269	CcSEcCtD
Levothyroxine—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000418	0.00268	CcSEcCtD
Levothyroxine—Nausea—Erlotinib—pancreatic cancer	0.000417	0.00268	CcSEcCtD
Levothyroxine—Mood swings—Doxorubicin—pancreatic cancer	0.000416	0.00267	CcSEcCtD
Levothyroxine—Diarrhoea—Sunitinib—pancreatic cancer	0.000416	0.00267	CcSEcCtD
Levothyroxine—Feeling abnormal—Irinotecan—pancreatic cancer	0.000413	0.00265	CcSEcCtD
Levothyroxine—Dysphagia—Epirubicin—pancreatic cancer	0.00041	0.00263	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000409	0.00263	CcSEcCtD
Levothyroxine—Dehydration—Doxorubicin—pancreatic cancer	0.000409	0.00262	CcSEcCtD
Levothyroxine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000402	0.00258	CcSEcCtD
Levothyroxine—Angina pectoris—Epirubicin—pancreatic cancer	0.0004	0.00257	CcSEcCtD
Levothyroxine—Body temperature increased—Irinotecan—pancreatic cancer	0.000396	0.00254	CcSEcCtD
Levothyroxine—Abdominal pain—Irinotecan—pancreatic cancer	0.000396	0.00254	CcSEcCtD
Levothyroxine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000395	0.00254	CcSEcCtD
Levothyroxine—Muscular weakness—Doxorubicin—pancreatic cancer	0.000388	0.00249	CcSEcCtD
Levothyroxine—Vomiting—Sunitinib—pancreatic cancer	0.000386	0.00248	CcSEcCtD
Levothyroxine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000385	0.00247	CcSEcCtD
Levothyroxine—Rash—Sunitinib—pancreatic cancer	0.000383	0.00246	CcSEcCtD
Levothyroxine—Dermatitis—Sunitinib—pancreatic cancer	0.000383	0.00246	CcSEcCtD
Levothyroxine—Urticaria—Fluorouracil—pancreatic cancer	0.000381	0.00244	CcSEcCtD
Levothyroxine—Headache—Sunitinib—pancreatic cancer	0.000381	0.00244	CcSEcCtD
Levothyroxine—Dysphagia—Doxorubicin—pancreatic cancer	0.00038	0.00244	CcSEcCtD
Levothyroxine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000379	0.00243	CcSEcCtD
Levothyroxine—Palpitations—Docetaxel—pancreatic cancer	0.000375	0.0024	CcSEcCtD
Levothyroxine—Weight decreased—Epirubicin—pancreatic cancer	0.000371	0.00238	CcSEcCtD
Levothyroxine—Angina pectoris—Doxorubicin—pancreatic cancer	0.00037	0.00237	CcSEcCtD
Levothyroxine—Convulsion—Docetaxel—pancreatic cancer	0.000367	0.00236	CcSEcCtD
Levothyroxine—Arthralgia—Docetaxel—pancreatic cancer	0.000361	0.00232	CcSEcCtD
Levothyroxine—Nausea—Sunitinib—pancreatic cancer	0.000361	0.00232	CcSEcCtD
Levothyroxine—Asthenia—Irinotecan—pancreatic cancer	0.000359	0.0023	CcSEcCtD
Levothyroxine—Sweating—Epirubicin—pancreatic cancer	0.000351	0.00225	CcSEcCtD
Levothyroxine—Asthenia—Gemcitabine—pancreatic cancer	0.00035	0.00225	CcSEcCtD
Levothyroxine—Confusional state—Docetaxel—pancreatic cancer	0.000349	0.00224	CcSEcCtD
Levothyroxine—Pruritus—Gemcitabine—pancreatic cancer	0.000345	0.00221	CcSEcCtD
Levothyroxine—Weight decreased—Doxorubicin—pancreatic cancer	0.000344	0.0022	CcSEcCtD
Levothyroxine—Diarrhoea—Irinotecan—pancreatic cancer	0.000343	0.0022	CcSEcCtD
Levothyroxine—Shock—Docetaxel—pancreatic cancer	0.00034	0.00218	CcSEcCtD
Levothyroxine—Pruritus—Fluorouracil—pancreatic cancer	0.000339	0.00218	CcSEcCtD
Levothyroxine—Tachycardia—Docetaxel—pancreatic cancer	0.000338	0.00217	CcSEcCtD
Levothyroxine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000334	0.00214	CcSEcCtD
Levothyroxine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000328	0.00211	CcSEcCtD
Levothyroxine—Sweating—Doxorubicin—pancreatic cancer	0.000325	0.00208	CcSEcCtD
Levothyroxine—Vomiting—Irinotecan—pancreatic cancer	0.000318	0.00204	CcSEcCtD
Levothyroxine—Rash—Irinotecan—pancreatic cancer	0.000316	0.00203	CcSEcCtD
Levothyroxine—Dermatitis—Irinotecan—pancreatic cancer	0.000315	0.00202	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000315	0.00202	CcSEcCtD
Levothyroxine—Headache—Irinotecan—pancreatic cancer	0.000314	0.00201	CcSEcCtD
Levothyroxine—Insomnia—Docetaxel—pancreatic cancer	0.000313	0.00201	CcSEcCtD
Levothyroxine—Vomiting—Gemcitabine—pancreatic cancer	0.00031	0.00199	CcSEcCtD
Levothyroxine—Dyspnoea—Docetaxel—pancreatic cancer	0.000309	0.00198	CcSEcCtD
Levothyroxine—Rash—Gemcitabine—pancreatic cancer	0.000307	0.00197	CcSEcCtD
Levothyroxine—Dermatitis—Gemcitabine—pancreatic cancer	0.000307	0.00197	CcSEcCtD
Levothyroxine—Headache—Gemcitabine—pancreatic cancer	0.000305	0.00196	CcSEcCtD
Levothyroxine—Flushing—Epirubicin—pancreatic cancer	0.000305	0.00196	CcSEcCtD
Levothyroxine—Vomiting—Fluorouracil—pancreatic cancer	0.000305	0.00196	CcSEcCtD
Levothyroxine—Rash—Fluorouracil—pancreatic cancer	0.000302	0.00194	CcSEcCtD
Levothyroxine—Dermatitis—Fluorouracil—pancreatic cancer	0.000302	0.00194	CcSEcCtD
Levothyroxine—Headache—Fluorouracil—pancreatic cancer	0.0003	0.00193	CcSEcCtD
Levothyroxine—Fatigue—Docetaxel—pancreatic cancer	0.000298	0.00191	CcSEcCtD
Levothyroxine—Nausea—Irinotecan—pancreatic cancer	0.000297	0.00191	CcSEcCtD
Levothyroxine—Arrhythmia—Epirubicin—pancreatic cancer	0.000293	0.00188	CcSEcCtD
Levothyroxine—Alopecia—Epirubicin—pancreatic cancer	0.00029	0.00186	CcSEcCtD
Levothyroxine—Nausea—Gemcitabine—pancreatic cancer	0.00029	0.00186	CcSEcCtD
Levothyroxine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000285	0.00183	CcSEcCtD
Levothyroxine—Nausea—Fluorouracil—pancreatic cancer	0.000285	0.00183	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000283	0.00182	CcSEcCtD
Levothyroxine—Flushing—Doxorubicin—pancreatic cancer	0.000282	0.00181	CcSEcCtD
Levothyroxine—Tension—Epirubicin—pancreatic cancer	0.000281	0.0018	CcSEcCtD
Levothyroxine—Nervousness—Epirubicin—pancreatic cancer	0.000278	0.00178	CcSEcCtD
Levothyroxine—Abdominal pain—Docetaxel—pancreatic cancer	0.000274	0.00176	CcSEcCtD
Levothyroxine—Body temperature increased—Docetaxel—pancreatic cancer	0.000274	0.00176	CcSEcCtD
Levothyroxine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000272	0.00174	CcSEcCtD
Levothyroxine—Alopecia—Doxorubicin—pancreatic cancer	0.000269	0.00172	CcSEcCtD
Levothyroxine—Agitation—Epirubicin—pancreatic cancer	0.000263	0.00169	CcSEcCtD
Levothyroxine—Tension—Doxorubicin—pancreatic cancer	0.00026	0.00167	CcSEcCtD
Levothyroxine—Nervousness—Doxorubicin—pancreatic cancer	0.000257	0.00165	CcSEcCtD
Levothyroxine—Palpitations—Epirubicin—pancreatic cancer	0.000253	0.00162	CcSEcCtD
Levothyroxine—Asthenia—Docetaxel—pancreatic cancer	0.000248	0.00159	CcSEcCtD
Levothyroxine—Convulsion—Epirubicin—pancreatic cancer	0.000248	0.00159	CcSEcCtD
Levothyroxine—Pruritus—Docetaxel—pancreatic cancer	0.000245	0.00157	CcSEcCtD
Levothyroxine—Arthralgia—Epirubicin—pancreatic cancer	0.000243	0.00156	CcSEcCtD
Levothyroxine—Agitation—Doxorubicin—pancreatic cancer	0.000243	0.00156	CcSEcCtD
Levothyroxine—Anxiety—Epirubicin—pancreatic cancer	0.000243	0.00156	CcSEcCtD
Levothyroxine—Diarrhoea—Docetaxel—pancreatic cancer	0.000237	0.00152	CcSEcCtD
Levothyroxine—Confusional state—Epirubicin—pancreatic cancer	0.000235	0.00151	CcSEcCtD
Levothyroxine—Palpitations—Doxorubicin—pancreatic cancer	0.000234	0.0015	CcSEcCtD
Levothyroxine—Shock—Epirubicin—pancreatic cancer	0.00023	0.00147	CcSEcCtD
Levothyroxine—Convulsion—Doxorubicin—pancreatic cancer	0.000229	0.00147	CcSEcCtD
Levothyroxine—Tachycardia—Epirubicin—pancreatic cancer	0.000228	0.00146	CcSEcCtD
Levothyroxine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000226	0.00145	CcSEcCtD
Levothyroxine—Arthralgia—Doxorubicin—pancreatic cancer	0.000225	0.00145	CcSEcCtD
Levothyroxine—Anxiety—Doxorubicin—pancreatic cancer	0.000225	0.00144	CcSEcCtD
Levothyroxine—Vomiting—Docetaxel—pancreatic cancer	0.00022	0.00141	CcSEcCtD
Levothyroxine—Rash—Docetaxel—pancreatic cancer	0.000218	0.0014	CcSEcCtD
Levothyroxine—Dermatitis—Docetaxel—pancreatic cancer	0.000218	0.0014	CcSEcCtD
Levothyroxine—Confusional state—Doxorubicin—pancreatic cancer	0.000218	0.0014	CcSEcCtD
Levothyroxine—Headache—Docetaxel—pancreatic cancer	0.000217	0.00139	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000213	0.00136	CcSEcCtD
Levothyroxine—Shock—Doxorubicin—pancreatic cancer	0.000212	0.00136	CcSEcCtD
Levothyroxine—Insomnia—Epirubicin—pancreatic cancer	0.000211	0.00135	CcSEcCtD
Levothyroxine—Tachycardia—Doxorubicin—pancreatic cancer	0.000211	0.00135	CcSEcCtD
Levothyroxine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000209	0.00134	CcSEcCtD
Levothyroxine—Dyspnoea—Epirubicin—pancreatic cancer	0.000208	0.00134	CcSEcCtD
Levothyroxine—Nausea—Docetaxel—pancreatic cancer	0.000206	0.00132	CcSEcCtD
Levothyroxine—Fatigue—Epirubicin—pancreatic cancer	0.000201	0.00129	CcSEcCtD
Levothyroxine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000197	0.00126	CcSEcCtD
Levothyroxine—Insomnia—Doxorubicin—pancreatic cancer	0.000195	0.00125	CcSEcCtD
Levothyroxine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000193	0.00124	CcSEcCtD
Levothyroxine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000192	0.00123	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000191	0.00122	CcSEcCtD
Levothyroxine—Fatigue—Doxorubicin—pancreatic cancer	0.000186	0.00119	CcSEcCtD
Levothyroxine—Urticaria—Epirubicin—pancreatic cancer	0.000185	0.00119	CcSEcCtD
Levothyroxine—Abdominal pain—Epirubicin—pancreatic cancer	0.000185	0.00118	CcSEcCtD
Levothyroxine—Body temperature increased—Epirubicin—pancreatic cancer	0.000185	0.00118	CcSEcCtD
Levothyroxine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000178	0.00114	CcSEcCtD
Levothyroxine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000177	0.00113	CcSEcCtD
Levothyroxine—Urticaria—Doxorubicin—pancreatic cancer	0.000172	0.0011	CcSEcCtD
Levothyroxine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000171	0.0011	CcSEcCtD
Levothyroxine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000171	0.0011	CcSEcCtD
Levothyroxine—Asthenia—Epirubicin—pancreatic cancer	0.000167	0.00107	CcSEcCtD
Levothyroxine—Pruritus—Epirubicin—pancreatic cancer	0.000165	0.00106	CcSEcCtD
Levothyroxine—Diarrhoea—Epirubicin—pancreatic cancer	0.00016	0.00102	CcSEcCtD
Levothyroxine—Asthenia—Doxorubicin—pancreatic cancer	0.000155	0.000994	CcSEcCtD
Levothyroxine—Pruritus—Doxorubicin—pancreatic cancer	0.000153	0.000981	CcSEcCtD
Levothyroxine—Vomiting—Epirubicin—pancreatic cancer	0.000148	0.000952	CcSEcCtD
Levothyroxine—Diarrhoea—Doxorubicin—pancreatic cancer	0.000148	0.000948	CcSEcCtD
Levothyroxine—Rash—Epirubicin—pancreatic cancer	0.000147	0.000944	CcSEcCtD
Levothyroxine—Dermatitis—Epirubicin—pancreatic cancer	0.000147	0.000944	CcSEcCtD
Levothyroxine—Headache—Epirubicin—pancreatic cancer	0.000146	0.000938	CcSEcCtD
Levothyroxine—Nausea—Epirubicin—pancreatic cancer	0.000139	0.00089	CcSEcCtD
Levothyroxine—Vomiting—Doxorubicin—pancreatic cancer	0.000137	0.000881	CcSEcCtD
Levothyroxine—Rash—Doxorubicin—pancreatic cancer	0.000136	0.000874	CcSEcCtD
Levothyroxine—Dermatitis—Doxorubicin—pancreatic cancer	0.000136	0.000873	CcSEcCtD
Levothyroxine—Headache—Doxorubicin—pancreatic cancer	0.000135	0.000868	CcSEcCtD
Levothyroxine—Nausea—Doxorubicin—pancreatic cancer	0.000128	0.000823	CcSEcCtD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.68e-05	0.000359	CbGpPWpGaD
Levothyroxine—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.67e-05	0.000358	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	4.61e-05	0.000353	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HES1—pancreatic cancer	4.59e-05	0.000352	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	4.55e-05	0.000349	CbGpPWpGaD
Levothyroxine—SLC7A5—Hemostasis—AKT1—pancreatic cancer	4.55e-05	0.000349	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.48e-05	0.000344	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	4.47e-05	0.000343	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.43e-05	0.000339	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—CD44—pancreatic cancer	4.41e-05	0.000338	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.32e-05	0.000331	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.28e-05	0.000328	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.27e-05	0.000327	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CD—pancreatic cancer	4.25e-05	0.000326	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—GCG—pancreatic cancer	4.23e-05	0.000324	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	4.19e-05	0.000321	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—CD44—pancreatic cancer	4.17e-05	0.00032	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GLP1R—pancreatic cancer	4.1e-05	0.000314	CbGpPWpGaD
Levothyroxine—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.09e-05	0.000313	CbGpPWpGaD
Levothyroxine—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	4.05e-05	0.00031	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	4.05e-05	0.00031	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IFNA1—pancreatic cancer	4.04e-05	0.00031	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—DPYD—pancreatic cancer	4.03e-05	0.000309	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—MYC—pancreatic cancer	4.02e-05	0.000308	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—MYC—pancreatic cancer	4.02e-05	0.000308	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TERT—pancreatic cancer	4.02e-05	0.000308	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—STK11—pancreatic cancer	3.97e-05	0.000305	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.89e-05	0.000298	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PRSS1—pancreatic cancer	3.85e-05	0.000295	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HIF1A—pancreatic cancer	3.85e-05	0.000295	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TSC2—pancreatic cancer	3.84e-05	0.000294	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PRSS1—pancreatic cancer	3.83e-05	0.000294	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—SLC2A2—pancreatic cancer	3.82e-05	0.000293	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.78e-05	0.00029	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—IFNA2—pancreatic cancer	3.76e-05	0.000288	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—APOE—pancreatic cancer	3.75e-05	0.000288	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.73e-05	0.000286	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CB—pancreatic cancer	3.71e-05	0.000284	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KDR—pancreatic cancer	3.68e-05	0.000282	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTGS2—pancreatic cancer	3.67e-05	0.000281	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.65e-05	0.00028	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	3.53e-05	0.000271	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NFKBIA—pancreatic cancer	3.5e-05	0.000268	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NOTCH1—pancreatic cancer	3.46e-05	0.000265	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—CD44—pancreatic cancer	3.46e-05	0.000265	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.44e-05	0.000264	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—TYMS—pancreatic cancer	3.42e-05	0.000262	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.39e-05	0.00026	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CG—pancreatic cancer	3.39e-05	0.00026	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.36e-05	0.000258	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PRSS1—pancreatic cancer	3.36e-05	0.000257	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGF—pancreatic cancer	3.35e-05	0.000257	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—ARG2—pancreatic cancer	3.34e-05	0.000256	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.33e-05	0.000255	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—ARG2—pancreatic cancer	3.32e-05	0.000255	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—GCG—pancreatic cancer	3.32e-05	0.000254	CbGpPWpGaD
Levothyroxine—TTR—Disease—CTNNB1—pancreatic cancer	3.29e-05	0.000252	CbGpPWpGaD
Levothyroxine—TTR—Disease—PTEN—pancreatic cancer	3.2e-05	0.000245	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.2e-05	0.000245	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—STK11—pancreatic cancer	3.12e-05	0.000239	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.11e-05	0.000239	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.08e-05	0.000236	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3e-05	0.00023	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CD—pancreatic cancer	2.98e-05	0.000228	CbGpPWpGaD
Levothyroxine—TTR—Disease—SRC—pancreatic cancer	2.97e-05	0.000228	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—CD44—pancreatic cancer	2.96e-05	0.000227	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.93e-05	0.000225	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMP—pancreatic cancer	2.92e-05	0.000224	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—ARG2—pancreatic cancer	2.91e-05	0.000223	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMP—pancreatic cancer	2.9e-05	0.000223	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.9e-05	0.000222	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.87e-05	0.00022	CbGpPWpGaD
Levothyroxine—TTR—Disease—STAT3—pancreatic cancer	2.86e-05	0.00022	CbGpPWpGaD
Levothyroxine—TTR—Disease—NRAS—pancreatic cancer	2.86e-05	0.000219	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—GCG—pancreatic cancer	2.84e-05	0.000218	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	2.83e-05	0.000217	CbGpPWpGaD
Levothyroxine—THRB—Gene Expression—AKT1—pancreatic cancer	2.79e-05	0.000214	CbGpPWpGaD
Levothyroxine—THRA—Gene Expression—AKT1—pancreatic cancer	2.79e-05	0.000214	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.79e-05	0.000214	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—APOE—pancreatic cancer	2.78e-05	0.000213	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	2.76e-05	0.000211	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.71e-05	0.000208	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—TYMS—pancreatic cancer	2.69e-05	0.000206	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PLAU—pancreatic cancer	2.67e-05	0.000205	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—STK11—pancreatic cancer	2.67e-05	0.000205	CbGpPWpGaD
Levothyroxine—TTR—Disease—MYC—pancreatic cancer	2.66e-05	0.000204	CbGpPWpGaD
Levothyroxine—TTR—Disease—TGFB1—pancreatic cancer	2.66e-05	0.000204	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.63e-05	0.000202	CbGpPWpGaD
Levothyroxine—TTR—Disease—EGFR—pancreatic cancer	2.6e-05	0.0002	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CB—pancreatic cancer	2.6e-05	0.000199	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMP—pancreatic cancer	2.54e-05	0.000195	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	2.53e-05	0.000194	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CG—pancreatic cancer	2.51e-05	0.000192	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.51e-05	0.000192	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.5e-05	0.000191	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CXCL8—pancreatic cancer	2.49e-05	0.000191	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.49e-05	0.000191	CbGpPWpGaD
Levothyroxine—TTR—Disease—KRAS—pancreatic cancer	2.46e-05	0.000189	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.44e-05	0.000187	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PPARG—pancreatic cancer	2.42e-05	0.000186	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.41e-05	0.000185	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.4e-05	0.000184	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CASP3—pancreatic cancer	2.39e-05	0.000183	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CG—pancreatic cancer	2.38e-05	0.000182	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GLP1R—pancreatic cancer	2.35e-05	0.00018	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—EGF—pancreatic cancer	2.35e-05	0.00018	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GLP1R—pancreatic cancer	2.34e-05	0.000179	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.33e-05	0.000178	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CCND1—pancreatic cancer	2.32e-05	0.000178	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—DPYD—pancreatic cancer	2.32e-05	0.000177	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.31e-05	0.000177	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—DPYD—pancreatic cancer	2.3e-05	0.000176	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—CTNNB1—pancreatic cancer	2.3e-05	0.000176	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—TYMS—pancreatic cancer	2.3e-05	0.000176	CbGpPWpGaD
Levothyroxine—TTR—Disease—PIK3CA—pancreatic cancer	2.26e-05	0.000173	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MMP9—pancreatic cancer	2.26e-05	0.000173	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PTEN—pancreatic cancer	2.24e-05	0.000172	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CD—pancreatic cancer	2.21e-05	0.000169	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—SLC2A2—pancreatic cancer	2.2e-05	0.000168	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—SLC2A2—pancreatic cancer	2.19e-05	0.000167	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—APOE—pancreatic cancer	2.18e-05	0.000167	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.17e-05	0.000167	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	2.16e-05	0.000166	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	2.15e-05	0.000165	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.12e-05	0.000162	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.1e-05	0.000161	CbGpPWpGaD
Levothyroxine—TTR—Disease—HRAS—pancreatic cancer	2.09e-05	0.00016	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CD—pancreatic cancer	2.09e-05	0.00016	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	2.09e-05	0.00016	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—SRC—pancreatic cancer	2.08e-05	0.000159	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	2.07e-05	0.000159	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.07e-05	0.000158	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GLP1R—pancreatic cancer	2.05e-05	0.000157	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.05e-05	0.000157	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—VEGFA—pancreatic cancer	2.03e-05	0.000155	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—DPYD—pancreatic cancer	2.02e-05	0.000155	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—STAT3—pancreatic cancer	2.01e-05	0.000154	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—NRAS—pancreatic cancer	2e-05	0.000153	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	1.97e-05	0.000151	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CB—pancreatic cancer	1.92e-05	0.000147	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—SLC2A2—pancreatic cancer	1.91e-05	0.000147	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.91e-05	0.000147	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTGS2—pancreatic cancer	1.9e-05	0.000146	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PPARG—pancreatic cancer	1.9e-05	0.000146	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.9e-05	0.000146	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—APOE—pancreatic cancer	1.87e-05	0.000143	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—MYC—pancreatic cancer	1.86e-05	0.000143	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TGFB1—pancreatic cancer	1.86e-05	0.000143	CbGpPWpGaD
Levothyroxine—TTR—Disease—AKT1—pancreatic cancer	1.85e-05	0.000141	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—EGFR—pancreatic cancer	1.82e-05	0.00014	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CB—pancreatic cancer	1.82e-05	0.000139	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.79e-05	0.000137	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.77e-05	0.000135	CbGpPWpGaD
Levothyroxine—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	1.76e-05	0.000135	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	1.73e-05	0.000133	CbGpPWpGaD
Levothyroxine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.73e-05	0.000133	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—KRAS—pancreatic cancer	1.72e-05	0.000132	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—CD44—pancreatic cancer	1.7e-05	0.00013	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—CD44—pancreatic cancer	1.69e-05	0.00013	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CG—pancreatic cancer	1.69e-05	0.000129	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.67e-05	0.000128	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PTEN—pancreatic cancer	1.66e-05	0.000127	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.66e-05	0.000127	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.65e-05	0.000127	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	1.64e-05	0.000126	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—GCG—pancreatic cancer	1.63e-05	0.000125	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PPARG—pancreatic cancer	1.63e-05	0.000125	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—GCG—pancreatic cancer	1.62e-05	0.000124	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—PIK3CA—pancreatic cancer	1.58e-05	0.000121	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.57e-05	0.00012	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—STK11—pancreatic cancer	1.53e-05	0.000118	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—TP53—pancreatic cancer	1.53e-05	0.000117	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—STK11—pancreatic cancer	1.53e-05	0.000117	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	1.51e-05	0.000116	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	1.5e-05	0.000115	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—CD44—pancreatic cancer	1.48e-05	0.000114	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CD—pancreatic cancer	1.48e-05	0.000114	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—HRAS—pancreatic cancer	1.46e-05	0.000112	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—SRC—pancreatic cancer	1.46e-05	0.000112	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.44e-05	0.00011	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.43e-05	0.00011	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—GCG—pancreatic cancer	1.42e-05	0.000109	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—VEGFA—pancreatic cancer	1.42e-05	0.000109	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—NRAS—pancreatic cancer	1.4e-05	0.000108	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—STK11—pancreatic cancer	1.34e-05	0.000102	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—TYMS—pancreatic cancer	1.32e-05	0.000101	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—TYMS—pancreatic cancer	1.31e-05	0.000101	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PTEN—pancreatic cancer	1.31e-05	0.0001	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TGFB1—pancreatic cancer	1.3e-05	9.99e-05	CbGpPWpGaD
Levothyroxine—TTR—Signaling Pathways—AKT1—pancreatic cancer	1.29e-05	9.91e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CB—pancreatic cancer	1.29e-05	9.9e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTGS2—pancreatic cancer	1.28e-05	9.81e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.26e-05	9.68e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.24e-05	9.53e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—KRAS—pancreatic cancer	1.21e-05	9.26e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.18e-05	9.04e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—PIK3CA—pancreatic cancer	1.17e-05	8.98e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—TYMS—pancreatic cancer	1.15e-05	8.81e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PTEN—pancreatic cancer	1.12e-05	8.55e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—PIK3CA—pancreatic cancer	1.11e-05	8.5e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—TP53—pancreatic cancer	1.07e-05	8.23e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—APOE—pancreatic cancer	1.07e-05	8.22e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—APOE—pancreatic cancer	1.07e-05	8.18e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—HRAS—pancreatic cancer	1.03e-05	7.87e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.02e-05	7.79e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.01e-05	7.74e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CG—pancreatic cancer	9.69e-06	7.42e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CG—pancreatic cancer	9.63e-06	7.38e-05	CbGpPWpGaD
Levothyroxine—SLCO1B3—Metabolism—AKT1—pancreatic cancer	9.57e-06	7.34e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—APOE—pancreatic cancer	9.35e-06	7.17e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PPARG—pancreatic cancer	9.35e-06	7.16e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PPARG—pancreatic cancer	9.29e-06	7.12e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	9.21e-06	7.06e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—CD44—pancreatic cancer	9.13e-06	7e-05	CbGpPWpGaD
Levothyroxine—ALB—Hemostasis—AKT1—pancreatic cancer	9.06e-06	6.95e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—GCG—pancreatic cancer	8.76e-06	6.71e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CD—pancreatic cancer	8.51e-06	6.53e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CD—pancreatic cancer	8.47e-06	6.49e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CG—pancreatic cancer	8.44e-06	6.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—STK11—pancreatic cancer	8.23e-06	6.31e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PPARG—pancreatic cancer	8.14e-06	6.24e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—PIK3CA—pancreatic cancer	7.87e-06	6.03e-05	CbGpPWpGaD
Levothyroxine—SLCO1A2—Metabolism—AKT1—pancreatic cancer	7.52e-06	5.76e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CB—pancreatic cancer	7.42e-06	5.69e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CD—pancreatic cancer	7.42e-06	5.68e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CB—pancreatic cancer	7.38e-06	5.66e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTGS2—pancreatic cancer	7.35e-06	5.64e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTGS2—pancreatic cancer	7.31e-06	5.6e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—TYMS—pancreatic cancer	7.08e-06	5.43e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CB—pancreatic cancer	6.47e-06	4.96e-05	CbGpPWpGaD
Levothyroxine—SLCO1B1—Metabolism—AKT1—pancreatic cancer	6.43e-06	4.93e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PTEN—pancreatic cancer	6.41e-06	4.91e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTGS2—pancreatic cancer	6.41e-06	4.91e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PTEN—pancreatic cancer	6.38e-06	4.89e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—APOE—pancreatic cancer	5.76e-06	4.41e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PTEN—pancreatic cancer	5.59e-06	4.28e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	5.2e-06	3.98e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PPARG—pancreatic cancer	5.02e-06	3.85e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	4.57e-06	3.5e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—PIK3CA—pancreatic cancer	4.52e-06	3.47e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—PIK3CA—pancreatic cancer	4.5e-06	3.45e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.98e-06	3.05e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.95e-06	3.02e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—PIK3CA—pancreatic cancer	3.94e-06	3.02e-05	CbGpPWpGaD
Levothyroxine—CYP2C8—Metabolism—AKT1—pancreatic cancer	3.7e-06	2.83e-05	CbGpPWpGaD
Levothyroxine—ALB—Metabolism—AKT1—pancreatic cancer	3.67e-06	2.82e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PTEN—pancreatic cancer	3.44e-06	2.64e-05	CbGpPWpGaD
Levothyroxine—ABCB1—Metabolism—AKT1—pancreatic cancer	3.22e-06	2.47e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.43e-06	1.86e-05	CbGpPWpGaD
Levothyroxine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.98e-06	1.52e-05	CbGpPWpGaD
